-
Precision CRISPR Tools Make the Cut
Genome-Editing Tools Modify More than Genomes
-
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
-
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
-
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
For full access to this article login to GEN Select now.
May 15, 2011 (Vol. 31, No. 10)
CROs Adapt to Meet Changing Paradigms
As Pharma Activities Narrow, Contract Research Organizations Rapidly Increase Their Offerings
- In its goal to advance safe, effective, and profitable drugs to market, the pharmaceutical industry has long acknowledged contract research as an essential resource. But as several CROs discussed at Select Biosciences’ recent “Pharma Outsourcing Congress”, the CRO-pharma relationship has been integrally changing in response to pharma’s new challenges ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
-
- Do not put any letters or characters here if you are not a spy program.